Video Experimental Relacionado
Updated: Jul 26, 2026
10:32
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Published on: June 5, 2015
Anticorpos antiidiotípicos de origen natural en pacientes con miastenia gravis
Nature
|February 17, 1983
Resumen
Los investigadores descubrieron anticuerpos anti-idiotipo de origen natural en pacientes con miastenia gravis. Estos autoanticuerpos pueden desempeñar un papel en la respuesta autoinmune observada en la miastenia gravis, afectando a los receptores nicotínicos de acetilcolina.
Área de la Ciencia:
- Inmunología Inmunología.
- Neuroinmunología La neuroinmunología.
- Enfermedades autoinmunes Las enfermedades autoinmunes.
Sus antecedentes:
- La regulación inmune aberrante puede causar enfermedades autoinmunes como la miastenia gravis (MG).
- En la MG, los autoanticuerpos dirigidos a los receptores nicotínicos de acetilcolina (AChR) reducen los niveles de receptores en la unión neuromuscular, causando fatiga muscular.
- Las interacciones de red idiotipo-antiidiotipo alteradas son una causa potencial de la respuesta autoinmune en la MG.
Objetivo del estudio:
- Para investigar el papel potencial de los anticuerpos anti-idiotipo en la patogénesis de la miastenia gravis.
- Desarrollar y utilizar un ensayo inmunosorbente vinculado a enzimas (ELISA) para detectar las inmunoglobulinas anti-AChR.
Principales métodos:
- Un anticuerpo monoclonal anti-AChR (ACR-24) fue inmovilizado en placas de microtitrado.
- Se agregaron sueros humanos para detectar anticuerpos anti-AChR.
- El ensayo se adaptó para detectar anticuerpos que se unen solo a ACR-24.
Principales resultados:
- El ensayo inmunosorbente vinculado a enzimas (ELISA) midió con éxito la inmunoglobulina anti-AChR en suero humano.
- Un hallazgo inesperado fue la detección de anticuerpos en ciertos pacientes con miastenia que se unen al anticuerpo monoclonal ACR-24 independientemente de AChR.
- Esto sugiere la presencia de anticuerpos anti-idiotipo de origen natural en el suero miasténico.
Conclusiones:
- El estudio identificó anticuerpos anti-idiotipo de origen natural en pacientes con miastenia gravis.
- Estos hallazgos sugieren un nuevo mecanismo en el proceso autoinmune de la MG, potencialmente involucrando la red idiotipo-anti-idiotipo.
- Se requiere más investigación para dilucidar el papel preciso de estos anticuerpos anti-idiotipo en la fisiopatología de MG.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...